» Articles » PMID: 11375276

Phosphorylation of Troponin I by Protein Kinase A Accelerates Relaxation and Crossbridge Cycle Kinetics in Mouse Ventricular Muscle

Overview
Journal Circ Res
Date 2001 May 26
PMID 11375276
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphorylation of cardiac myofibrils by cAMP-dependent protein kinase (PKA) can increase the intrinsic rate of myofibrillar relaxation, which may contribute to the shortening of the cardiac twitch during beta-adrenoceptor stimulation. However, it is not known whether the acceleration of myofibrillar relaxation is due to phosphorylation of troponin I (TnI) or of myosin binding protein-C (MyBP-C). To distinguish between these possibilities, we used transgenic mice that overexpress the nonphosphorylatable, slow skeletal isoform of TnI in the myocardium and do not express the normal, phosphorylatable cardiac TNI: The intrinsic rate of relaxation of myofibrils from wild-type and transgenic mice was measured using flash photolysis of diazo-2 to rapidly decrease the [Ca(2+)] within skinned muscles from the mouse ventricles. Incubation with PKA nearly doubled the intrinsic rate of myofibrillar relaxation in muscles from wild-type mice (relaxation half-time fell from approximately 150 to approximately 90 ms at 22 degrees C) but had no effect on the relaxation rate of muscles from the transgenic mice. In parallel studies with intact muscles, we assessed crossbridge kinetics indirectly by determining f(min) (the frequency for minimum dynamic stiffness) during tetanic contractions. Stimulation of beta-adrenoceptors with isoproterenol increased f(min) from 1.9 to 3.1 Hz in muscles from wild-type mice but had no effect on f(min) in muscles from transgenic mice. We conclude that the acceleration of myofibrillar relaxation rate by PKA is due to phosphorylation of TnI, rather than MyBP-C, and that this may be due, at least in part, to faster crossbridge cycle kinetics.

Citing Articles

Molecular Regulation of Cardiomyocyte Maturation.

Shewale B, Ebrahim T, Samal A, Dubois N Curr Cardiol Rep. 2025; 27(1):32.

PMID: 39836238 DOI: 10.1007/s11886-024-02189-1.


Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations , , and .

Yang Z, Sheehan A, Messer A, Tsui S, Sparrow A, Redwood C Front Physiol. 2024; 15:1489439.

PMID: 39735723 PMC: 11672104. DOI: 10.3389/fphys.2024.1489439.


Mechanism-based myofilament manipulation to treat diastolic dysfunction in HFpEF.

Dominic K, Schmidt A, Granzier H, Campbell K, Stelzer J Front Physiol. 2024; 15:1512550.

PMID: 39726859 PMC: 11669688. DOI: 10.3389/fphys.2024.1512550.


Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation.

Lynn M, Jimenez J, Castillo R, Vasquez C, Klass M, Baldo A Circ Res. 2024; 135(10):974-989.

PMID: 39328062 PMC: 11502267. DOI: 10.1161/CIRCRESAHA.124.325223.


Alterations in cardiac contractile and regulatory proteins contribute to age-related cardiac dysfunction in male rats.

Han Y, Pakkam M, Fogarty M, Sieck G, Brozovich F Physiol Rep. 2024; 12(16):e70012.

PMID: 39169429 PMC: 11338742. DOI: 10.14814/phy2.70012.